26 articles · page 1 of 3 · showing 1 to 12
Clinical trial protocol automation can turn study schedules and assessment requirements into draft EDC forms, field specifications and edit checks. Reliable results depend on traceable source mapping, testing and human approval.
AI systems can link regulatory document claims to clinical evidence, but every citation still needs source, version and context checks. Learn how controlled reviews and audit trails protect…
Medical affairs teams collect scientific questions and observations from the field. AI can organize those records and flag recurring themes, but evidence verification, privacy and safety…
Healthcare claims denial prediction uses historical reimbursement data, payer rules, and machine learning to identify billing risks before submission. Learn how predictive models work, what…
Healthleap raised $38 million to expand its AI platform that analyses hospital records and flags patients who may need further clinical review.
The FDA is prioritising guidance on AI medical devices, generative AI and robotically assisted surgical systems for fiscal 2027.
Explore 10 AI healthcare tools that help doctors and hospitals improve clinical workflows, medical imaging, documentation, and personalised patient care in 2026.
AI is helping healthcare companies analyse ECGs, cardiac imaging and wearable data to improve cardiovascular risk assessment and support earlier heart care decisions.
AI startup EliseAI has raised $350 million at a $4 billion valuation to expand its AI platform for housing and healthcare operations.
Precision Neuroscience raises $250 million to advance its brain-computer interface technology, focusing on implantable neural devices that translate brain signals into digital commands.
AI-powered blood tests from companies like GRAIL, Guardant Health and Freenome are exploring new ways to detect cancer signals through molecular data.
AI is being used to match patients, select trial sites, analyse clinical data and support drug development as AI-designed candidates reach later-stage trials.
